TechCancer vaccine reportedly succeeds in preventing melanoma recurrence in trial
Trials of mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway, The Washington Post reports.
TLDR
The Washington Post reports that a cancer vaccine succeeded in a clinical trial at preventing melanoma from recurring, a result experts call a breakthrough for mRNA-based treatments. The paper also says trials of mRNA vaccines for lung cancer, pancreatic cancer and other diseases are underway.
Combined views
150.4K
1 Source, first seen 23h ago
Cancer vaccine reportedly succeeds in preventing melanoma recurrence in trial
Trials of mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway, The Washington Post reports.
TLDR
The Washington Post reports that a cancer vaccine succeeded in a clinical trial at preventing melanoma from recurring, a result experts call a breakthrough for mRNA-based treatments. The paper also says trials of mRNA vaccines for lung cancer, pancreatic cancer and other diseases are underway.